Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.07.2022 | Case report

Lubiprostone/risperidone/selegiline

Constipation and pedal oedema: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Demler TL, et al. Challenges associated with treating and preventing antipsychotic-induced constipation: Considerations and cautions when prescribing novel interventions. International Clinical Psychopharmacology : 12-17, Jan 2020. Available from: URL: http://doi.org/10.1097/YIC.0000000000000331 Demler TL, et al. Challenges associated with treating and preventing antipsychotic-induced constipation: Considerations and cautions when prescribing novel interventions. International Clinical Psychopharmacology : 12-17, Jan 2020. Available from: URL: http://​doi.​org/​10.​1097/​YIC.​0000000000000331​
Metadaten
Titel
Lubiprostone/risperidone/selegiline
Constipation and pedal oedema: case report
Publikationsdatum
01.07.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-19290-z

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

Esomeprazole

Case report

Nitroglycerin

Case report

Multiple drugs

Case report

Latanoprost

Case report

Multiple drugs